Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Paul V Fish

17PUBLICATIONS
19CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsProteins and peptidesNatural products and bioactive compoundsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

Sort by Publication Date:
|Oct 24, 2022
Large-scale synthesis of Notum inhibitor 1-(2,4-dichloro-3-(trifluoromethyl)-phenyl)-1<i>H</i>-1,2,3-triazole (ARUK3001185) employing a modified Sakai reaction as the key step.

Benjamin N Atkinson, Nicky J Willis, Jennifer Smith

|Jun 22, 2022
Structural Analysis and Development of Notum Fragment Screening Hits.

Yuguang Zhao, William Mahy, Nicky J Willis

|May 10, 2022
Design of a Potent, Selective, and Brain-Penetrant Inhibitor of Wnt-Deactivating Enzyme Notum by Optimization of a Crystallographic Fragment Hit.

Nicky J Willis, William Mahy, James Sipthorp

|Dec 23, 2021
Virtual Screening Directly Identifies New Fragment-Sized Inhibitors of Carboxylesterase Notum with Nanomolar Activity.

David Steadman, Benjamin N Atkinson, Yuguang Zhao

|Apr 22, 2021
Small-molecule inhibitors of carboxylesterase Notum.

Yuguang Zhao, Sarah Jolly, Stefano Benvegnu

|Mar 30, 2021
Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling.

Elliott D Bayle, Fredrik Svensson, Benjamin N Atkinson

Pageof 3

Frequent Collaborators

8 joint publications

Benjamin N Atkinson

6 joint publications

Hannah L Woodward

6 joint publications

David Steadman

6 joint publications

Yuguang Zhao

6 joint publications

E Yvonne Jones

5 joint publications

Fredrik Svensson

5 joint publications

Nicky J Willis

3 joint publications

Kelly Chibale

2 joint publications

Paul E Brennan

2 joint publications

Stefan Knapp

Frequent Collaborators

8 joint publications

Benjamin N Atkinson

6 joint publications

Hannah L Woodward

6 joint publications

David Steadman

6 joint publications

Yuguang Zhao

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

1.2K
NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on : Jun 04, 2021

3.4K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on : Oct 26, 2015

11.4K
See more related videos

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

1.2K
NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on : Jun 04, 2021

3.4K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on : Oct 26, 2015

11.4K
See more related videos